跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Elesclomol Copper
首页
药物
Elesclomol Copper
Elesclomol Copper
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of illicit
CN 118557556 A
申请人: UNIV SHANTOU
优先权: 2024
CN
COMPOUNDS AND USES THEREOF
WO 2025260130 A1
申请人: UNIV MELBOURNE
优先权: 2024
WO
METHODS FOR TREATING DISORDERS OF COPPER METABOLISM
WO 2026015861 A1
申请人: ENGRAIL THERAPEUTICS INC
优先权: 2024
WO
METHOD OF USING COPPER-LOADED COPPER IONOPHORES TO OVERCOME RADIORESISTANCE
WO 2026060174 A1
申请人: UNIV TEXAS
优先权: 2024
WO
Zirconium-copper bimetallic nano-material, preparation method and application of zirconium-copper bimetallic nano-material in preparation of medicine for treating breast cancer
CN 120459315 A
申请人: CHINESE PEOPLES LIBERATION ARMY AIR FORCE CHARACTERISTIC MEDICAL CENTER
优先权: 2025
CN
Pharmaceutical composition for improving pancreatic cancer treatment effect
CN 121550254 A
申请人: ZHEJIANG CANCER HOSPITAL
优先权: 2026
CN
药物
反馈